Operating Grant: Clinical Trials Projects
Canadian Institutes of Health Research (CIHR)
This funding opportunity will support projects relevant to at least one of the following research areas: Clinical trials for new or repurposed drugs (including vaccines and biologic drugs) and medical devices (such as diagnostic tests) to prevent or respond to health emergencies*; and/or, early phase (pilot, Phase 1 and Phase 2) clinical trials of safety and efficacy to support the development and commercialization of new health products with high potential to solve current and future health challenges (such as pandemics, antimicrobial resistance, and other health emergencies).
The total amount available for this funding opportunity is $41,600,000 over 3 years; there is no annual or total cap per grant.
Anticipated Notice of Decision: April 17, 2024
Funding Start Date: April 1, 2024
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 22-Aug-2023 |
Application | 09-Nov-2023 4:30 pm CST | 21-Nov-2023 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.